Low-Methoxy Pectin in Frailty
Current understanding
A small 4-week double-blind RCT (n=29 completers) in frail older adults reported that low-methoxy (LM) pectin supplementation improved 30-second sit-to-stand performance, HADS anxiety/depression scores, and several SF-36 quality-of-life domains, alongside an increase in gut Coprococcus comes, while circulating inflammatory biomarkers were unchanged [human-rct]. The signal is preliminary — short duration, small sample, surrogate and functional endpoints rather than frailty transitions or mortality — and sits within the broader soluble-fibre/SCFA hypothesis for the gut-muscle axis [mechanism-plausible].
Evidence log
- 2026-09-28 — The effect of pectin supplementation on geriatric individuals with frailty: a randomised placebo-controlled dietary intervention study.: cross-connection with soluble-dietary-fiber: LM pectin is a specific soluble, fermentable fibre; this trial provides the first direct human functional-endpoint data for the broader SCFA-producing fibre page. (novelty: 3)